List of Tables:
TABLE 1 MARKET SYNOPSIS
TABLE 2 LIST OF ASSUMPTIONS
TABLE 3 PRIMARY INTERVIEWS
TABLE 4 GLOBAL TRANSIENT ISCHEMIC ATTACK MARKET, BY DIAGNOSIS, 2014-2023 (USD Million)
TABLE 5 GLOBAL TRANSIENT ISCHEMIC ATTACK MARKET FOR DIAGNOSIS, BY IMAGING TECHNIQUES, 2014-2023 (USD Million)
TABLE 6 GLOBAL TRANSIENT ISCHEMIC ATTACK MARKET FOR IMAGING TECHNIQUES, BY COMPUTED TOMOGRAPHY (CT) SCAN, 2014-2023 (USD Million)
TABLE 7 GLOBAL TRANSIENT ISCHEMIC ATTACK MARKET FOR IMAGING TECHNIQUES, BY CAROTID DUPLEX SCANNING, 2014-2023 (USD Million)
TABLE 8 GLOBAL TRANSIENT ISCHEMIC ATTACK MARKET FOR IMAGING TECHNIQUES, BY MAGNETIC RESONANCE IMAGING, 2014-2023 (USD Million)
TABLE 9 GLOBAL TRANSIENT ISCHEMIC ATTACK MARKET FOR IMAGING TECHNIQUES, BY ECHOCARDIOGRAPHY, 2014-2023 (USD Million)
TABLE 10 GLOBAL TRANSIENT ISCHEMIC ATTACK MARKET, BY TREATMENT, 2014-2023 (USD Million)
TABLE 11 GLOBAL TRANSIENT ISCHEMIC ATTACK MARKET FOR TREATMENT, BY SURGERY, 2014-2023 (USD Million)
TABLE 12 GLOBAL TRANSIENT ISCHEMIC ATTACK MARKET FOR TREATMENT, BY DRUGS, 2014-2023 (USD Million)
TABLE 13 GLOBAL TRANSIENT ISCHEMIC ATTACK MARKET FOR DRUG, BY ANTITHROMBOTIC AGENTS, 2014-2023 (USD Million)
TABLE 14 GLOBAL TRANSIENT ISCHEMIC ATTACK MARKET FOR ANTITHROMBOTIC AGENTS, BY ANTIPLATELETS, 2014-2023 (USD Million)
TABLE 15 GLOBAL TRANSIENT ISCHEMIC ATTACK MARKET FOR ANTIPLATELETS, BY CLOPIDOGREL, 2014-2023 (USD Million)
TABLE 16 GLOBAL TRANSIENT ISCHEMIC ATTACK MARKET FOR ANTIPLATELETS, BY ASPIRIN, 2014-2023 (USD Million)
TABLE 17 GLOBAL TRANSIENT ISCHEMIC ATTACK MARKET FOR ANTITHROMBOTIC AGENTS, BY HEPARINS, 2014-2023 (USD Million)
TABLE 18 GLOBAL TRANSIENT ISCHEMIC ATTACK MARKET FOR HEPARINS, BY ENOXAPARIN, 2014-2023 (USD Million)
TABLE 19 GLOBAL TRANSIENT ISCHEMIC ATTACK MARKET FOR HEPARINS, BY DALTEPARIN, 2014-2023 (USD Million)
TABLE 20 GLOBAL TRANSIENT ISCHEMIC ATTACK MARKET FOR ANTITHROMBOTIC AGENTS, BY FIBRINOLYTICS, 2014-2023 (USD Million)
TABLE 21 GLOBAL TRANSIENT ISCHEMIC ATTACK MARKET FOR FIBRINOLYTICS, BY TENECTEPLASE, 2014-2023 (USD Million)
TABLE 22 GLOBAL TRANSIENT ISCHEMIC ATTACK MARKET FOR FIBRINOLYTICS, BY ALTEPLASE 2014-2023 (USD Million)
TABLE 23 GLOBAL TRANSIENT ISCHEMIC ATTACK MARKET FOR DRUGS, BY ANTIHYPERTENSIVE AGENTS, 2014-2023 (USD Million)
TABLE 24 GLOBAL TRANSIENT ISCHEMIC ATTACK MARKET FOR ANTIHYPERTENSIVE AGENTS, BY PRAZOSIN, 2014-2023 (USD Million)
TABLE 25 GLOBAL TRANSIENT ISCHEMIC ATTACK MARKET FOR ANTIHYPERTENSIVE AGENTS, BY MOXONIDINE, 2014-2023 (USD Million)
TABLE 26 GLOBAL TRANSIENT ISCHEMIC ATTACK MARKET, BY AGE GROUPS, 2014-2023 (USD Million)
TABLE 27 GLOBAL TRANSIENT ISCHEMIC ATTACK MARKET FOR AGE GROUP, BY 0-18 YEARS, 2014-2023 (USD Million)
TABLE 28 GLOBAL TRANSIENT ISCHEMIC ATTACK MARKET FOR AGE GROUP, BY 19-40 YEARS, 2014-2023 (USD Million)
TABLE 29 GLOBAL TRANSIENT ISCHEMIC ATTACK MARKET FOR AGE GROUP, BY 41-60 YEARS, 2014-2023 (USD Million)
TABLE 30 GLOBAL TRANSIENT ISCHEMIC ATTACK MARKET FOR AGE GROUP, BY 60+ YEARS, 2014-2023 (USD Million)
TABLE 31 GLOBAL TRANSIENT ISCHEMIC ATTACK MARKET, BY END-USER, 2014-2023 (USD Million)
TABLE 32 GLOBAL TRANSIENT ISCHEMIC ATTACK MARKET FOR HOSPITALS, BY REGION, 2014-2023 (USD Million)
TABLE 33 GLOBAL TRANSIENT ISCHEMIC ATTACK MARKET FOR DIAGNOSTIC CENTERS, BY REGION, 2014-2023 (USD Million)
TABLE 34 GLOBAL TRANSIENT ISCHEMIC ATTACK MARKET FOR RESEARCH LABORATORIES, BY REGION, 2014-2023 (USD Million)
TABLE 35 GLOBAL TRANSIENT ISCHEMIC ATTACK MARKET, BY REGION, 2014-2023 (USD Million)
TABLE 36 AMERICAS TRANSIENT ISCHEMIC ATTACK MARKET, BY REGION, 2014-2023 (USD Million)
TABLE 37 AMERICAS TRANSIENT ISCHEMIC ATTACK MARKET, BY DIAGNOSIS, 2014-2023 (USD Million)
TABLE 38 AMERICAS TRANSIENT ISCHEMIC ATTACK MARKET FOR DIAGNOSIS, BY IMAGING TECHNIQUE, 2014-2023 (USD Million)
TABLE 39 AMERICAS TRANSIENT ISCHEMIC ATTACK MARKET BY TREATMENT,, 2014-2023 (USD Million)
TABLE 40 AMERICAS TRANSIENT ISCHEMIC ATTACK MARKET FOR TREATMENT, BY DRUGS, 2014-2023 (USD Million)
TABLE 41 AMERICAS TRANSIENT ISCHEMIC ATTACK MARKET FOR DRUGS, BY ANTITHROMBOTIC AGENTS, 2014-2023 (USD Million)
TABLE 42 AMERICAS TRANSIENT ISCHEMIC ATTACK MARKET FOR ANTITHROMBOTIC AGENTS, BY ANTIPLATELETS, 2014-2023 (USD Million)
TABLE 43 AMERICAS TRANSIENT ISCHEMIC ATTACK MARKET FOR ANTITHROMBOTIC AGENTS, BY HEPARINS, 2014-2023 (USD Million)
TABLE 44 AMERICAS TRANSIENT ISCHEMIC ATTACK MARKET FOR ANTITHROMBOTIC AGENTS, BY FIBRINOLYTICS, 2014-2023 (USD Million)
TABLE 45 AMERICAS TRANSIENT ISCHEMIC ATTACK MARKET FOR DRUGS, BY ANTIHYPERTENSIVE AGENTS, 2014-2023 (USD Million)
TABLE 46 AMERICAS TRANSIENT ISCHEMIC ATTACK MARKET, BY AGE GROUP, 2014-2023 (USD Million)
TABLE 47 AMERICAS TRANSIENT ISCHEMIC ATTACK MARKET, BY END-USER, 2014-2023 (USD Million)
TABLE 48 North America: TRANSIENT ISCHEMIC ATTACK MARKET, BY COUNTRY, 2014-2023 (USD Million)
TABLE 49 North America TRANSIENT ISCHEMIC ATTACK MARKET, BY DIAGNOSIS, 2014-2023 (USD Million)
TABLE 50 North America TRANSIENT ISCHEMIC ATTACK MARKET FOR DIAGNOSIS, BY IMAGING TECHNIQUE, 2014-2023 (USD Million)
TABLE 51 North America TRANSIENT ISCHEMIC ATTACK MARKET BY TREATMENT, 2014-2023 (USD Million)
TABLE 52 North America TRANSIENT ISCHEMIC ATTACK MARKET FOR TREATMENT, BY DRUGS, 2014-2023 (USD Million)
TABLE 53 North America TRANSIENT ISCHEMIC ATTACK MARKET FOR DRUGS, BY ANTITHROMBOTIC AGENTS, 2014-2023 (USD Million)
TABLE 54 North America TRANSIENT ISCHEMIC ATTACK MARKET FOR ANTITHROMBOTIC AGENTS, BY ANTIPLATELETS, 2014-2023 (USD Million)
TABLE 55 North America TRANSIENT ISCHEMIC ATTACK MARKET FOR ANTITHROMBOTIC AGENTS, BY HEPARINS, 2014-2023 (USD Million)
TABLE 56 North America TRANSIENT ISCHEMIC ATTACK MARKET FOR ANTITHROMBOTIC AGENTS, BY FIBRINOLYTICS, 2014-2023 (USD Million)
TABLE 57 North America TRANSIENT ISCHEMIC ATTACK MARKET FOR DRUGS, BY ANTIHYPERTENSIVE AGENTS, 2014-2023 (USD Million)
TABLE 58 North America TRANSIENT ISCHEMIC ATTACK MARKET, BY AGE GROUP, 2014-2023 (USD Million)
TABLE 59 North America TRANSIENT ISCHEMIC ATTACK MARKET, BY END-USER, 2014-2023 (USD Million)
TABLE 60 U.S. TRANSIENT ISCHEMIC ATTACK MARKET, BY DIAGNOSIS, 2014-2023 (USD Million)
TABLE 61 U.S. TRANSIENT ISCHEMIC ATTACK MARKET FOR DIAGNOSIS, BY IMAGING TECHNIQUE, 2014-2023 (USD Million)
TABLE 62 U.S. TRANSIENT ISCHEMIC ATTACK MARKET BY TREATMENT,, 2014-2023 (USD Million)
TABLE 63 U.S. TRANSIENT ISCHEMIC ATTACK MARKET FOR TREATMENT, BY DRUGS, 2014-2023 (USD Million)
TABLE 64 U.S. TRANSIENT ISCHEMIC ATTACK MARKET FOR DRUGS, BY ANTITHROMBOTIC AGENTS 2014-2023 (USD Million)
TABLE 65 U.S. TRANSIENT ISCHEMIC ATTACK MARKET FOR ANTITHROMBOTIC AGENTS, BY ANTIPLATELETS, 2014-2023 (USD Million)
TABLE 66 U.S. TRANSIENT ISCHEMIC ATTACK MARKET FOR ANTITHROMBOTIC AGENTS, BY HEPARINS, 2014-2023 (USD Million)
TABLE 67 U.S. TRANSIENT ISCHEMIC ATTACK MARKET FOR ANTITHROMBOTIC AGENTS, BY FIBRINOLYTICS, 2014-2023 (USD Million)
TABLE 68 U.S. TRANSIENT ISCHEMIC ATTACK MARKET FOR DRUGS, BY ANTIHYPERTENSIVE AGENTS, 2014-2023 (USD Million)
TABLE 69 U.S. TRANSIENT ISCHEMIC ATTACK MARKET, BY AGE GROUP, 2014-2023 (USD Million)
TABLE 70 U.S. TRANSIENT ISCHEMIC ATTACK MARKET, BY END-USER, 2014-2023 (USD Million)
TABLE 71 Canada TRANSIENT ISCHEMIC ATTACK MARKET, BY DIAGNOSIS, 2014-2023 (USD Million)
TABLE 72 Canada TRANSIENT ISCHEMIC ATTACK MARKET FOR DIAGNOSIS, BY IMAGING TECHNIQUE, 2014-2023 (USD Million)
TABLE 73 Canada TRANSIENT ISCHEMIC ATTACK MARKET BY TREATMENT,, 2014-2023 (USD Million)
TABLE 74 Canada TRANSIENT ISCHEMIC ATTACK MARKET FOR TREATMENT, BY DRUGS, 2014-2023 (USD Million)
TABLE 75 Canada TRANSIENT ISCHEMIC ATTACK MARKET FOR DRUGS, BY ANTITHROMBOTIC AGENTS, 2014-2023 (USD Million)
TABLE 76 Canada TRANSIENT ISCHEMIC ATTACK MARKET FOR ANTITHROMBOTIC AGENTS, BY ANTIPLATELETS, 2014-2023 (USD Million)
TABLE 77 Canada TRANSIENT ISCHEMIC ATTACK MARKET FOR ANTITHROMBOTIC AGENTS, BY HEPARINS, 2014-2023 (USD Million)
TABLE 78 Canada TRANSIENT ISCHEMIC ATTACK MARKET FOR ANTITHROMBOTIC AGENTS, BY FIBRINOLYTICS, 2014-2023 (USD Million)
TABLE 79 Canada TRANSIENT ISCHEMIC ATTACK MARKET FOR DRUGS, BY ANTIHYPERTENSIVE AGENTS, 2014-2023 (USD Million)
TABLE 80 Canada TRANSIENT ISCHEMIC ATTACK MARKET, BY AGE GROUP, 2014-2023 (USD Million)
TABLE 81 Canada TRANSIENT ISCHEMIC ATTACK MARKET, BY END-USER, 2014-2023 (USD Million)
TABLE 82 SOUTH AMERICA TRANSIENT ISCHEMIC ATTACK MARKET, BY DIAGNOSIS, 2014-2023 (USD Million)
TABLE 83 SOUTH AMERICA TRANSIENT ISCHEMIC ATTACK MARKET FOR DIAGNOSIS, BY IMAGING TECHNIQUE, 2014-2023 (USD Million)
TABLE 84 SOUTH AMERICA TRANSIENT ISCHEMIC ATTACK MARKET BY TREATMENT, 2014-2023 (USD Million)
TABLE 85 SOUTH AMERICA TRANSIENT ISCHEMIC ATTACK MARKET FOR TREATMENT, BY DRUGS, 2014-2023 (USD Million)
TABLE 86 SOUTH AMERICA TRANSIENT ISCHEMIC ATTACK MARKET FOR DRUGS, BY ANTITHROMBOTIC AGENTS, 2014-2023 (USD Million)
TABLE 87 SOUTH AMERICA TRANSIENT ISCHEMIC ATTACK MARKET FOR ANTITHROMBOTIC AGENTS, BY ANTIPLATELETS, 2014-2023 (USD Million)
TABLE 88 SOUTH AMERICA TRANSIENT ISCHEMIC ATTACK MARKET FOR ANTITHROMBOTIC AGENTS, BY HEPARINS, 2014-2023 (USD Million)
TABLE 89 SOUTH AMERICA TRANSIENT ISCHEMIC ATTACK MARKET FOR ANTITHROMBOTIC AGENTS, BY FIBRINOLYTICS, 2014-2023 (USD Million)
TABLE 90 SOUTH AMERICA TRANSIENT ISCHEMIC ATTACK MARKET FOR DRUGS, BY ANTIHYPERTENSIVE AGENTS, 2014-2023 (USD Million)
TABLE 91 SOUTH AMERICA TRANSIENT ISCHEMIC ATTACK MARKET, BY AGE GROUP, 2014-2023 (USD Million)
TABLE 92 SOUTH AMERICA TRANSIENT ISCHEMIC ATTACK MARKET, BY END-USER, 2014-2023 (USD Million)
TABLE 93 EUROPE TRANSIENT ISCHEMIC ATTACK MARKET, BY COUNTRY, 2014-2023 (USD Million)
TABLE 94 EUROPE TRANSIENT ISCHEMIC ATTACK MARKET, BY DIAGNOSIS, 2014-2023 (USD Million)
TABLE 95 EUROPE TRANSIENT ISCHEMIC ATTACK MARKET FOR DIAGNOSIS, BY IMAGING TECHNIQUE, 2014-2023 (USD Million)
TABLE 96 EUROPE TRANSIENT ISCHEMIC ATTACK MARKET BY TREATMENT,, 2014-2023 (USD Million)
TABLE 97 EUROPE TRANSIENT ISCHEMIC ATTACK MARKET FOR TREATMENT, BY DRUGS, 2014-2023 (USD Million)
TABLE 98 EUROPE TRANSIENT ISCHEMIC ATTACK MARKET FOR DRUGS, BY ANTITHROMBOTIC AGENTS, 2014-2023 (USD Million)
TABLE 99 EUROPE TRANSIENT ISCHEMIC ATTACK MARKET FOR ANTITHROMBOTIC AGENTS, BY ANTIPLATELETS, 2014-2023 (USD Million)
TABLE 100 EUROPE TRANSIENT ISCHEMIC ATTACK MARKET FOR ANTITHROMBOTIC AGENTS, BY HEPARINS, 2014-2023 (USD Million)
TABLE 101 EUROPE TRANSIENT ISCHEMIC ATTACK MARKET FOR ANTITHROMBOTIC AGENTS, BY FIBRINOLYTICS, 2014-2023 (USD Million)
TABLE 102 EUROPE TRANSIENT ISCHEMIC ATTACK MARKET FOR DRUGS, BY ANTIHYPERTENSIVE AGENTS, 2014-2023 (USD Million)
TABLE 103 EUROPE TRANSIENT ISCHEMIC ATTACK MARKET, BY AGE GROUP, 2014-2023 (USD Million)
TABLE 104 EUROPE TRANSIENT ISCHEMIC ATTACK MARKET, BY END-USER, 2014-2023 (USD Million)
TABLE 105 WESTERN EUROPE TRANSIENT ISCHEMIC ATTACK MARKET, BY DIAGNOSIS, 2014-2023 (USD Million)
TABLE 106 WESTERN EUROPE TRANSIENT ISCHEMIC ATTACK MARKET FOR DIAGNOSIS, BY IMAGING TECHNIQUE, 2014-2023 (USD Million)
TABLE 107 WESTERN EUROPE TRANSIENT ISCHEMIC ATTACK MARKET BY TREATMENT, 2014-2023 (USD Million)
TABLE 108 WESTERN EUROPE TRANSIENT ISCHEMIC ATTACK MARKET FOR TREATMENT, BY DRUGS, 2014-2023 (USD Million)
TABLE 109 WESTERN EUROPE TRANSIENT ISCHEMIC ATTACK MARKET FOR DRUGS, BY ANTITHROMBOTIC AGENTS, 2014-2023 (USD Million)
TABLE 110 WESTERN EUROPE TRANSIENT ISCHEMIC ATTACK MARKET FOR ANTITHROMBOTIC AGENTS, BY ANTIPLATELETS, 2014-2023 (USD Million)
TABLE 111 WESTERN EUROPE TRANSIENT ISCHEMIC ATTACK MARKET FOR ANTITHROMBOTIC AGENTS, BY HEPARINS, 2014-2023 (USD Million)
TABLE 112 WESTERN EUROPE TRANSIENT ISCHEMIC ATTACK MARKET FOR ANTITHROMBOTIC AGENTS, BY FIBRINOLYTICS, 2014-2023 (USD Million)
TABLE 113 WESTERN EUROPE TRANSIENT ISCHEMIC ATTACK MARKET FOR DRUGS, BY ANTIHYPERTENSIVE AGENTS, 2014-2023 (USD Million)
TABLE 114 WESTERN EUROPE TRANSIENT ISCHEMIC ATTACK MARKET, BY AGE GROUP, 2014-2023 (USD Million)
TABLE 115 WESTERN EUROPE TRANSIENT ISCHEMIC ATTACK MARKET, BY END-USER, 2014-2023 (USD Million)
TABLE 116 GERMANY TRANSIENT ISCHEMIC ATTACK MARKET, BY DIAGNOSIS, 2014-2023 (USD Million)
TABLE 117 GERMANY TRANSIENT ISCHEMIC ATTACK MARKET FOR DIAGNOSIS, BY IMAGING TECHNIQUE, 2014-2023 (USD Million)
TABLE 118 GERMANY TRANSIENT ISCHEMIC ATTACK MARKET BY TREATMENT, 2014-2023 (USD Million)
TABLE 119 GERMANY TRANSIENT ISCHEMIC ATTACK MARKET FOR TREATMENT, BY DRUGS, 2014-2023 (USD Million)
TABLE 120 GERMANY TRANSIENT ISCHEMIC ATTACK MARKET FOR DRUGS, BY ANTITHROMBOTIC AGENTS, 2014-2023 (USD Million)
TABLE 121 GERMANY TRANSIENT ISCHEMIC ATTACK MARKET FOR ANTITHROMBOTIC AGENTS, BY ANTIPLATELETS,
2014-2023 (USD Million)
TABLE 122 GERMANY TRANSIENT ISCHEMIC ATTACK MARKET FOR ANTITHROMBOTIC AGENTS, BY HEPARINS,
2014-2023 (USD Million)
TABLE 123 GERMANY TRANSIENT ISCHEMIC ATTACK MARKET FOR ANTITHROMBOTIC AGENTS, BY FIBRINOLYTICS,
2014-2023 (USD Million)
TABLE 124 GERMANY TRANSIENT ISCHEMIC ATTACK MARKET FOR DRUGS, BY ANTIHYPERTENSIVE AGENTS, 2014-2023 (USD Million)
TABLE 125 GERMANY TRANSIENT ISCHEMIC ATTACK MARKET, BY AGE GROUP, 2014-2023 (USD Million)
TABLE 126 GERMANY TRANSIENT ISCHEMIC ATTACK MARKET, BY END-USER, 2014-2023 (USD Million)
TABLE 127 FRANCE TRANSIENT ISCHEMIC ATTACK MARKET, BY DIAGNOSIS, 2014-2023 (USD Million)
TABLE 128 FRANCE TRANSIENT ISCHEMIC ATTACK MARKET FOR DIAGNOSIS, BY IMAGING TECHNIQUE, 2014-2023 (USD Million)
TABLE 129 FRANCE TRANSIENT ISCHEMIC ATTACK MARKET BY TREATMENT, 2014-2023 (USD Million)
TABLE 130 FRANCE TRANSIENT ISCHEMIC ATTACK MARKET FOR TREATMENT, BY DRUGS, 2014-2023 (USD Million)
TABLE 131 FRANCE TRANSIENT ISCHEMIC ATTACK MARKET FOR DRUGS, BY ANTITHROMBOTIC AGENTS, 2014-2023 (USD Million)
TABLE 132 FRANCE TRANSIENT ISCHEMIC ATTACK MARKET FOR ANTITHROMBOTIC AGENTS, BY ANTIPLATELETS,
2014-2023 (USD Million)
TABLE 133 FRANCE TRANSIENT ISCHEMIC ATTACK MARKET FOR ANTITHROMBOTIC AGENTS, BY HEPARINS, 2014-2023 (USD Million)
TABLE 134 FRANCE TRANSIENT ISCHEMIC ATTACK MARKET FOR ANTITHROMBOTIC AGENTS, BY FIBRINOLYTICS,
2014-2023 (USD Million)
TABLE 135 FRANCE TRANSIENT ISCHEMIC ATTACK MARKET FOR DRUGS, BY ANTIHYPERTENSIVE AGENTS, 2014-2023 (USD Million)
TABLE 136 FRANCE TRANSIENT ISCHEMIC ATTACK MARKET, BY AGE GROUP, 2014-2023 (USD Million)
TABLE 137 FRANCE TRANSIENT ISCHEMIC ATTACK MARKET, BY END-USER, 2014-2023 (USD Million)
TABLE 138 U.K TRANSIENT ISCHEMIC ATTACK MARKET, BY DIAGNOSIS, 2014-2023 (USD Million)
TABLE 139 U.K TRANSIENT ISCHEMIC ATTACK MARKET FOR DIAGNOSIS, BY IMAGING TECHNIQUE, 2014-2023 (USD Million)
TABLE 140 U.K TRANSIENT ISCHEMIC ATTACK MARKET BY TREATMENT,, 2014-2023 (USD Million)
TABLE 141 U.K TRANSIENT ISCHEMIC ATTACK MARKET FOR TREATMENT, BY DRUGS, 2014-2023 (USD Million)
TABLE 142 U.K TRANSIENT ISCHEMIC ATTACK MARKET FOR DRUGS, BY ANTITHROMBOTIC AGENTS, 2014-2023 (USD Million)
TABLE 143 U.K TRANSIENT ISCHEMIC ATTACK MARKET FOR ANTITHROMBOTIC AGENTS, BY ANTIPLATELETS, 2014-2023 (USD Million)
TABLE 144 U.K TRANSIENT ISCHEMIC ATTACK MARKET FOR ANTITHROMBOTIC AGENTS, BY HEPARINS, 2014-2023 (USD Million)
TABLE 145 U.K TRANSIENT ISCHEMIC ATTACK MARKET FOR ANTITHROMBOTIC AGENTS, BY FIBRINOLYTICS, 2014-2023 (USD Million)
TABLE 146 U.K TRANSIENT ISCHEMIC ATTACK MARKET FOR DRUGS, BY ANTIHYPERTENSIVE AGENTS, 2014-2023 (USD Million)
TABLE 147 U.K TRANSIENT ISCHEMIC ATTACK MARKET, BY AGE GROUP, 2014-2023 (USD Million)
TABLE 148 U.K TRANSIENT ISCHEMIC ATTACK MARKET, BY END-USER, 2014-2023 (USD Million)
TABLE 149 ITALY TRANSIENT ISCHEMIC ATTACK MARKET, BY DIAGNOSIS, 2014-2023 (USD Million)
TABLE 150 ITALY TRANSIENT ISCHEMIC ATTACK MARKET FOR DIAGNOSIS, BY IMAGING TECHNIQUE, 2014-2023 (USD Million)
TABLE 151 ITALY TRANSIENT ISCHEMIC ATTACK MARKET BY TREATMENT, 2014-2023 (USD Million)
TABLE 152 ITALY TRANSIENT ISCHEMIC ATTACK MARKET FOR TREATMENT, BY DRUGS, 2014-2023 (USD Million)
TABLE 153 ITALY TRANSIENT ISCHEMIC ATTACK MARKET FOR DRUGS, BY ANTITHROMBOTIC AGENTS 2014-2023 (USD Million)
TABLE 154 ITALY TRANSIENT ISCHEMIC ATTACK MARKET FOR ANTITHROMBOTIC AGENTS, BY ANTIPLATELETS,
2014-2023 (USD Million)
TABLE 155 ITALY TRANSIENT ISCHEMIC ATTACK MARKET FOR ANTITHROMBOTIC AGENTS, BY HEPARINS, 2014-2023 (USD Million)
TABLE 156 ITALY TRANSIENT ISCHEMIC ATTACK MARKET FOR ANTITHROMBOTIC AGENTS, BY FIBRINOLYTICS,
2014-2023 (USD Million)
TABLE 157 ITALY TRANSIENT ISCHEMIC ATTACK MARKET FOR DRUGS, BY ANTIHYPERTENSIVE AGENTS, 2014-2023 (USD Million)
TABLE 158 ITALY TRANSIENT ISCHEMIC ATTACK MARKET, BY AGE GROUP, 2014-2023 (USD Million)
TABLE 159 ITALY TRANSIENT ISCHEMIC ATTACK MARKET, BY END-USER, 2014-2023 (USD Million)
TABLE 160 SPAIN TRANSIENT ISCHEMIC ATTACK MARKET, BY DIAGNOSIS, 2014-2023 (USD Million)
TABLE 161 SPAIN TRANSIENT ISCHEMIC ATTACK MARKET FOR DIAGNOSIS, BY IMAGING TECHNIQUE, 2014-2023 (USD Million)
TABLE 162 SPAIN TRANSIENT ISCHEMIC ATTACK MARKET BY TREATMENT,, 2014-2023 (USD Million)
TABLE 163 SPAIN TRANSIENT ISCHEMIC ATTACK MARKET FOR TREATMENT, BY DRUGS, 2014-2023 (USD Million)
TABLE 164 SPAIN TRANSIENT ISCHEMIC ATTACK MARKET FOR DRUGS, BY ANTITHROMBOTIC AGENTS, 2014-2023 (USD Million)
TABLE 165 SPAIN TRANSIENT ISCHEMIC ATTACK MARKET FOR ANTITHROMBOTIC AGENTS, BY ANTIPLATELETS,
2014-2023 (USD Million)
TABLE 166 SPAIN TRANSIENT ISCHEMIC ATTACK MARKET FOR ANTITHROMBOTIC AGENTS, BY HEPARINS, 2014-2023 (USD Million)
TABLE 167 SPAIN TRANSIENT ISCHEMIC ATTACK MARKET FOR ANTITHROMBOTIC AGENTS, BY FIBRINOLYTICS,
2014-2023 (USD Million)
TABLE 168 SPAIN TRANSIENT ISCHEMIC ATTACK MARKET FOR DRUGS, BY ANTIHYPERTENSIVE AGENTS, 2014-2023 (USD Million)
TABLE 169 SPAIN TRANSIENT ISCHEMIC ATTACK MARKET, BY AGE GROUP, 2014-2023 (USD Million)
TABLE 170 SPAIN TRANSIENT ISCHEMIC ATTACK MARKET, BY END-USER, 2014-2023 (USD Million)
LIST OF FIGURE
List of Figures:
FIGURE 1 GLOBAL TRANSIENT ISCHEMIC ATTACK MARKET: MARKET STRUCTURE
FIGURE 2 RESEARCH PROCESS OF MRFR
FIGURE 3 TOP-DOWN & BOTTOM-UP APPROACH
FIGURE 4 DRIVERS & RESTRAINTS: GLOBAL TRANSIENT ISCHEMIC ATTACK MARKET
FIGURE 5 PORTERS FIVE FORCES MODEL
FIGURE 6 SUPPLY CHAIN: TRANSIENT ISCHEMIC ATTACK MARKET
FIGURE 7 GLOBAL TRANSIENT ISCHEMIC ATTAK MARKET, BY DIAGNOSIS, 2017 (% SHARE)
FIGURE 8 GLOBAL TRANSIENT ISCHEMIC ATTACK MARKET, BY DIAGNOSIS, 2014 TO 2023 (USD Million)
FIGURE 9 GLOBAL TRANSIENT ISCHEMIC ATTAK MARKET, BY TREATMENT 2017 (% SHARE)
FIGURE 10 GLOBAL TRANSIENT ISCHEMIC ATTACK MARKET, BY TREATMENT, 2014 TO 2023 (USD Million)
FIGURE 11 GLOBAL TRANSIENT ISCHEMIC ATTAK MARKET, BY AGE GROUP 2017 (% SHARE)
FIGURE 12 GLOBAL TRANSIENT ISCHEMIC ATTACK MARKET, BY AGE GROUPS, 2014 TO 2023 (USD Million)
FIGURE 13 GLOBAL TRANSIENT ISCHEMIC ATTAK MARKET, BY END USER 2017 (% SHARE)
FIGURE 14 GLOBAL TRANSIENT ISCHEMIC ATTACK MARKET, BY END-USER, 2014 TO 2023 (USD Million)
FIGURE 15 GLOBAL TRANSIENT ISCHEMIC ATTACK MARKET, BY REGION, 2014 TO 2023 (USD Million)
FIGURE 16 AMERICAS TRANSIENT ISCHEMIC ATTACK MARKET, BY REGION, 2017 (%)
FIGURE 17 North America: TRANSIENT ISCHEMIC ATTACK MARKET SHARE, BY COUNTRY, 2017 (% SHARE)
FIGURE 18 EUROPE TRANSIENT ISCHEMIC ATTACK MARKET, BY COUNTRY, 2017 (%)
FIGURE 19 ASIA PACIFIC TRANSIENT ISCHEMIC ATTACK MARKET, BY COUNTRY, 2017 (%)
FIGURE 20 MIDDLE EAST & AFRICA TRANSIENT ISCHEMIC ATTACK MARKET, BY COUNTRY, 2017 (%)
FIGURE 21 GLOBAL TRANSIENT ISCHEMIC ATTACK MARKET, COMPANY SHARE ANALYSIS 2016 (%)
FIGURE 22 GLOBAL TRANSIENT ISCHEMIC ATTACK MARKET COMPETITIVE LANDSCAPE (%)
